Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Azitra Inc

AZTR
0,4753
0,0033 (0,70%)
Ultimo aggiornamento: 17:53:46
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/11/202423:05PRNUSAzitra, Inc. Announces Q3 2024 Financial Results and..
12/11/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202414:00BWAzitra to Present at BIO-Europe 2024
11/10/202415:00BWAzitra to Participate in the 2024 Maxim Healthcare Virtual..
09/10/202423:01EDGAR2Form ARS - Annual Report to Security Holders
09/10/202422:55EDGAR2Form DEF 14A - Other definitive proxy statements
24/9/202414:00BWAzitra, Inc. Announces Late-Breaking Presentation at the..
18/9/202415:00BWAzitra Receives Fast Track Designation for ATR-04 for Skin..
16/9/202423:47EDGAR2Form 144 - Report of proposed sale of securities
06/9/202422:30BWAzitra to Present at the H.C. Wainwright 26th Annual Global..
28/8/202414:30BWAzitra Announces First Patient Dosed in Phase 1b Trial of..
22/8/202415:00BWAzitra Receives Study May Proceed letter from the FDA for..
20/8/202422:15BWAzitra Announces First Patient Screened and Scheduled to..
13/8/202400:23BWAzitra, Inc. Announces Q2 2024 Financial Results and..
12/8/202423:15EDGAR2Form 8-K - Current report
12/8/202423:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202422:05EDGAR2Form SC 13D/A - General Statement of Acquisition of..
29/7/202422:01EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
26/7/202422:05EDGAR2Form 8-K - Current report
25/7/202423:57BWCORRECTING and REPLACING Azitra, Inc. Announces Closing of..
25/7/202420:15BWAzitra, Inc. Announces Closing of Public Offering
25/7/202412:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/7/202403:20BWAzitra, Inc. Announces Pricing of $10.0 Million Public..
23/7/202414:00BWAzitra, Inc. Strengthens Global Intellectual Property..
19/7/202423:27EDGAR2Form S-1/A - General form for registration of securities..
15/7/202423:11EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
15/7/202412:21EDGAR2Form S-1 - General form for registration of securities under..
27/6/202422:05BWAzitra, Inc. Announces Reverse Stock Split
03/6/202422:30EDGAR2Form DEF 14A - Other definitive proxy statements
31/5/202414:00BWAzitra, Inc. Announces Presentation at the 2024 BIO..
24/5/202422:55EDGAR2Form PRE 14A - Other preliminary proxy statements
17/5/202414:00BWAzitra, Inc. Announces Positive Preclinical Data from ATR-04..
10/5/202414:00BWAzitra, Inc. Announces Positive Preclinical Data of ATR-12..
09/5/202423:05EDGAR2Form 8-K - Current report
09/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202423:00BWAzitra, Inc. Announces Q1 2024 Financial Results and..
22/4/202422:30BWAzitra, Inc. Announces New Preclinical Data to be Presented..
18/4/202422:15BWAzitra, Inc. to Present New Data at Three Upcoming..
15/3/202421:15BWAzitra, Inc. Announces Full Year 2023 Financial Results and..
26/2/202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/2/202422:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/2/202422:05BWAzitra, Inc. Announces Closing of Public Offering
16/2/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202415:15EDGAR2Form 8-K - Current report
14/2/202404:09BWAzitra, Inc. Announces Pricing of Public Offering
19/1/202417:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
19/1/202415:19EDGAR2Form S-1 - General form for registration of securities under..
Apertura: 0,4771 Min: 0,4701 Max: 0,4825
Chiusura: 0,472

La tua Cronologia

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network